The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, uncontrolled and “true” treatment-resistant hypertension, according to data ...
Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.